7351 - 7400 of 7665 Results
Title
Year
- Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in Rats2011RESTRICTEDTitle: Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in RatsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 1106End Page: 1110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/jm101271sBest OA location URL: https://europepmc.org/articles/pmc3166797?pdf=renderCitation Count: 43
-
RESTRICTEDTitle: Use of Florbetapir-PET for Imaging β-Amyloid PathologyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 305Issue #: 3Start Page: 275End Page: 275Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2010.2008Best OA location URL: https://europepmc.org/articles/pmc7041965?pdf=renderCitation Count: 960
- Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease2011RESTRICTEDTitle: Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 25Issue #: 4Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.10-173625Best OA location URL: https://europepmc.org/articles/pmc3058704Citation Count: 115
- Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas2011RESTRICTEDTitle: Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomasJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 108Issue #: 4Start Page: 1439End Page: 1444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.1012500108Best OA location URL: https://europepmc.org/articles/pmc3029686?pdf=renderCitation Count: 85
- The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen2011RESTRICTEDTitle: The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and PosiphenJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 3Start Page: 493End Page: 507Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-010-0513-5Best OA location URL: https://europepmc.org/articles/pmc6625511?pdf=renderCitation Count: 58
- Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons2011RESTRICTEDTitle: Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neuronsJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 89Issue #: 3Start Page: 406End Page: 417Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/jnr.22549Best OA location URL: https://europepmc.org/articles/pmc6487665?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: Advances in Therapeutic Options for Gait and Balance in Parkinson’s DiseaseJournal Name: US NeurologyPublisher: Touch Medical Media, Ltd.Vol: 07Issue #: 02Start Page: 100End Page: 100Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17925/usn.2011.07.02.100Best OA location URL: http://www.touchneurology.com/wp-content/uploads/sites/3/2015/07/private_articles_10210_pdf_chou.pdfCitation Count: 18
- Basal Ganglia Disorders Associated with Imbalances in the Striatal Striosome and Matrix Compartments2011RESTRICTEDTitle: Basal Ganglia Disorders Associated with Imbalances in the Striatal Striosome and Matrix CompartmentsJournal Name: Frontiers in NeuroanatomyPublisher: Frontiers Media SAVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnana.2011.00059Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnana.2011.00059/pdfCitation Count: 350
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2011RESTRICTEDTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Best OA location URL: https://europepmc.org/articles/pmc3005012?pdf=renderCitation Count: 45
-
RESTRICTEDTitle: Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?Journal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2011Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.4061/2011/659694Best OA location URL: https://downloads.hindawi.com/journals/pd/2011/659694.pdfCitation Count: 10
- Effect of Deep Brain Stimulation on Parkinson's Nonmotor Symptoms following Unilateral DBS: A Pilot Study2011RESTRICTEDTitle: Effect of Deep Brain Stimulation on Parkinson's Nonmotor Symptoms following Unilateral DBS: A Pilot StudyJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2011Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.4061/2011/507416Best OA location URL: https://downloads.hindawi.com/journals/pd/2011/507416.pdfCitation Count: 21
- Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration2011RESTRICTEDTitle: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestorationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1370Issue #:Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006Best OA location URL: https://europepmc.org/articles/pmc3019295?pdf=renderCitation Count: 38
-
RESTRICTEDTitle: Expert Testimony at the Food and Drug Administration: Who Wants the Truth?Journal Name: Narrative Inquiry in BioethicsPublisher: Project MUSEVol: 1Issue #: 2Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1353/nib.2011.0046Best OA location URL: https://europepmc.org/articles/pmc4528642?pdf=renderCitation Count: 0
- MicelackingRas- GRF1 showcontextualfearcondition- ing butnotspatialmemoryimpair- ments:convergentevidencefromtwo independentlygeneratedmousemutant lines2011RESTRICTEDTitle: MicelackingRas- GRF1 showcontextualfearcondition- ing butnotspatialmemoryimpair- ments:convergentevidencefromtwo independentlygeneratedmousemutant linesJournal Name: Frontiers in Behavioral NeurosciencePublisher: Frontiers Media SAVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnbeh.2011.00078Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnbeh.2011.00078/pdfCitation Count: 20
-
RESTRICTEDTitle: Models for LRRK2-Linked ParkinsonismJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2011Issue #:Start Page: 1End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.4061/2011/942412Best OA location URL: https://downloads.hindawi.com/journals/pd/2011/942412.pdfCitation Count: 24
- Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluency2011RESTRICTEDTitle: Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluencyJournal Name: NeuroImagePublisher: Elsevier BVVol: 54Issue #:Start Page: S238End Page: S246Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2010.03.068Best OA location URL: https://europepmc.org/articles/pmc2908727?pdf=renderCitation Count: 102
-
RESTRICTEDTitle: Pre- and Post- GPi DBS Neuropsychological Profiles in a Case of X-Linked Dystonia-ParkinsonismJournal Name: The Clinical NeuropsychologistPublisher: Informa UK LimitedVol: 25Issue #: 1Start Page: 141End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/13854046.2010.532812Best OA location URL: https://europepmc.org/articles/pmc3070298?pdf=renderCitation Count: 7
-
RESTRICTEDTitle: Ras?ERK Signaling in Behavior: Old Questions and New PerspectivesJournal Name: Frontiers in Behavioral NeurosciencePublisher: Frontiers Media SAVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnbeh.2011.00079Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnbeh.2011.00079/pdfCitation Count: 51
-
RESTRICTEDTitle: Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 CasesJournal Name: Sleep DisordersPublisher: Hindawi LimitedVol: 2011Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2011/468952Best OA location URL: https://downloads.hindawi.com/journals/sd/2011/468952.pdfCitation Count: 7
- Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release2011RESTRICTEDTitle: Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged ReleaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2011Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.4061/2011/354760Best OA location URL: https://downloads.hindawi.com/journals/pd/2011/354760.pdfCitation Count: 8
-
RESTRICTEDTitle: Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine ReuptakeJournal Name: International Journal of Biological SciencesPublisher: Ivyspring International PublisherVol: 7Issue #: 6Start Page: 753End Page: 761Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.7150/ijbs.7.753Best OA location URL: https://www.ijbs.com/v07p0753.pdfCitation Count: 55
- Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative2011RESTRICTEDTitle: Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging InitiativeJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 68Issue #: 1Start Page: 58End Page: 58Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2010.343Best OA location URL: https://europepmc.org/articles/pmc3259850?pdf=renderCitation Count: 137
- Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning2010RESTRICTEDTitle: Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoningJournal Name: Journal of General PhysiologyPublisher: Rockefeller University PressVol: 137Issue #: 1Start Page: 59End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1085/jgp.201010532Best OA location URL: https://rupress.org/jgp/article-pdf/137/1/59/1187438/jgp_201010532.pdfCitation Count: 157
-
RESTRICTEDTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://europepmc.org/articles/pmc3159957?pdf=renderCitation Count: 76
-
RESTRICTEDTitle: Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implicationsJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 33Issue #: 12Start Page: 541End Page: 549Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2010.09.001Best OA location URL: https://europepmc.org/articles/pmc2981680?pdf=renderCitation Count: 190
- Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neurons2010RESTRICTEDTitle: Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neuronsJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 45Issue #: 4Start Page: 324End Page: 334Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2010.07.004Citation Count: 20
-
RESTRICTEDTitle: Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 686End Page: 687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.09.007Best OA location URL: https://europepmc.org/articles/pmc4381965?pdf=renderCitation Count: 37
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice2010RESTRICTEDTitle: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 40Issue #: 3Start Page: 503End Page: 517Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.07.010Best OA location URL: https://europepmc.org/articles/pmc2955774?pdf=renderCitation Count: 246
-
RESTRICTEDTitle: Molecular Chaperones as Rational Drug Targets for Parkinsons Disease TherapeuticsJournal Name: CNS & Neurological Disorders - Drug TargetsPublisher: Bentham Science Publishers Ltd.Vol: 9Issue #: 6Start Page: 741End Page: 753Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/187152710793237386Best OA location URL: https://europepmc.org/articles/pmc3364514?pdf=renderCitation Count: 92
- Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson Disease2010RESTRICTEDTitle: Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson DiseaseJournal Name: ChestPublisher: Elsevier BVVol: 138Issue #: 6Start Page: 1426End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1378/chest.10-0342Citation Count: 79
-
RESTRICTEDTitle: N‐acetylcysteine prevents loss of dopaminergic neurons in the EAAC1−/− mouseJournal Name: Annals of NeurologyPublisher: WileyVol: 69Issue #: 3Start Page: 509End Page: 520Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.22162Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.22162Citation Count: 123
- Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains2010RESTRICTEDTitle: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 1Start Page: 27End Page: 36Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23442Best OA location URL: https://europepmc.org/articles/pmc6333467?pdf=renderCitation Count: 149
-
RESTRICTEDTitle: HCN channelopathy in external globus pallidus neurons in models of Parkinson's diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 85End Page: 92Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nn.2692Best OA location URL: https://europepmc.org/articles/pmc3058391?pdf=renderCitation Count: 168
- Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease2010RESTRICTEDTitle: Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 226Issue #: 1Start Page: 207End Page: 217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.09.001Best OA location URL: https://europepmc.org/articles/pmc3108022?pdf=renderCitation Count: 48
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 55
-
RESTRICTEDTitle: SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein LevelJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 67Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2010.279Best OA location URL: https://europepmc.org/articles/pmc3010848?pdf=renderCitation Count: 149
-
RESTRICTEDTitle: Chaperone-mediated autophagy: machinery, regulation and biological consequencesJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 68Issue #: 5Start Page: 749End Page: 763Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-010-0565-6Citation Count: 111
- CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease2010RESTRICTEDTitle: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 1Start Page: 23End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5Best OA location URL: https://europepmc.org/articles/pmc3090073?pdf=renderCitation Count: 13
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?2010RESTRICTEDTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
-
RESTRICTEDTitle: PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 2Issue #: 52Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3001059Best OA location URL: https://europepmc.org/articles/pmc3129986?pdf=renderCitation Count: 709
-
RESTRICTEDTitle: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ncomms1085Best OA location URL: https://www.nature.com/articles/ncomms1085.pdfCitation Count: 142
-
RESTRICTEDTitle: Biomarkers in Parkinson’s disease: a funder’s perspectiveJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 723End Page: 729Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.89Citation Count: 15
- LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease2010RESTRICTEDTitle: LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 40Issue #: 1Start Page: 73End Page: 81Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.04.002Best OA location URL: https://europepmc.org/articles/pmc2926296?pdf=renderCitation Count: 126
-
RESTRICTEDTitle: Toxicological and pathophysiological roles of reactive oxygen and nitrogen speciesJournal Name: ToxicologyPublisher: Elsevier BVVol: 276Issue #: 2Start Page: 85End Page: 94Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tox.2010.07.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237863Citation Count: 180
-
RESTRICTEDTitle: Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosisJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 701End Page: 712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.94Best OA location URL: https://europepmc.org/articles/pmc3049925?pdf=renderCitation Count: 119
- Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis2010RESTRICTEDTitle: Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 82Issue #: 5Start Page: 564End Page: 568Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp.2010.222042Best OA location URL: https://europepmc.org/articles/pmc4646086?pdf=renderCitation Count: 89
-
RESTRICTEDTitle: Estimation of Particulate Mass and Manganese Exposure Levels among WeldersJournal Name: The Annals of Occupational HygienePublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/annhyg/meq069Best OA location URL: https://academic.oup.com/annweh/article-pdf/55/1/113/11209915/meq069.pdfCitation Count: 43
-
RESTRICTEDTitle: Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairmentJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 120Issue #: 6Start Page: 827End Page: 828Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-010-0744-4Best OA location URL: https://europepmc.org/articles/pmc3100801?pdf=renderCitation Count: 77
-
RESTRICTEDTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Best OA location URL: https://europepmc.org/articles/pmc2939261?pdf=renderCitation Count: 38
- Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations2010RESTRICTEDTitle: Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutationsJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1791End Page: 1800Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23221Best OA location URL: https://europepmc.org/articles/pmc6005705?pdf=renderCitation Count: 228